Please download this poster, “Validation of a 15-Color Spectral Flow Cytometry Panel for Globally Harmonized Comprehensive Leukocyte Profiling in Human Whole Blood: Translational and Clinical Applications “ CYTEK_ValidatedPanels_EBF2024_20241118Download…

Please download this poster, “Comparative Evaluation of Ligand Binding Assay Platforms for BiomarkerQuantification: Critical Considerations for Ensuring Data Quality and Project Success” LBAPlatforms_EBF2024_Poster_vfDownload…

KCAS Bio is thrilled to announce our attendance at the upcoming J.P. Morgan Healthcare Conference, a premier gathering that draws top leaders, decision-makers, and innovators from across the life sciences and healthcare industries. As we join this influential event in San Francisco, KCAS Bio is eager to connect with industry…

KCAS Bio is excited to sponsor the upcoming Pharmaceutical & BioScience Society (PBSS) workshop, “Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapies,” in Foster City, California. Dawn Dufield, Ph.D., will be presenting “Bioanalysis for Biologics and Cell/Gene Therapy Products…

Webinar Description: KCAS Bio will present results from a recent validation of two IP panels on the Cytek Aurora in PBMCs. We have analyzed the impact of different fixation buffers on the efficacy of reference controls over time, and we will explore how to help improve workflow standards and process…

KCAS Bio has embarked on a global initiative to harmonize its spectral flow cytometry services across four labs in three countries, collaborating with Crux Biolabs and Cytek Biosciences. This effort ensures standardized flow cytometry services across sites in the U.S., Europe, and Australia. As trials increasingly span multiple regions, global…

KCAS Bio is excited to announce our participation in several premier conferences throughout the United States this fall. These events bring together experts, innovators, and leaders in pharmaceuticals, biotechnology, and clinical research to exchange insights, explore the latest technologies, and drive the future of scientific discovery. As a trusted provider…

KCAS Bio is excited to announce our participation in several key conferences throughout the world. These events present invaluable opportunities for collaboration, innovation, and the sharing of industry insights. As a leading provider of bioanalytical services, KCAS Bio is committed to engaging with thought leaders, scientists, and professionals worldwide to…

KCAS Bio is excited to announce our participation in the 39th International Clinical Cytometry Meeting and Course (ICCS), taking place in Seattle, Washington. This prestigious event will bring together global experts in cytometry to explore the latest advancements in clinical applications, research, and innovation. As a leader in bioanalytical services,…

KCAS Bio is thrilled to participate in BioJapan 2024, one of Asia’s most prominent biotechnology events, held in Yokohama, Japan. As a leader in bioanalytical and contract research services, our presence at BioJapan underscores our commitment to providing world-class solutions to the global biotech industry. This event offers an unparalleled…

As the pharmaceutical industry continues to evolve, so does the technology behind drug development. One of the most groundbreaking advancements in bioanalysis is Hybrid LC-MS/MS technology, which is rapidly becoming the new standard for analyzing Antibody Drug Conjugates (ADCs). KCAS Bio is proud to be at the forefront of this…

KCAS Bio is excited to announce our attendance at AusBiotech 2024 in Melbourne, Australia. As a leader in bioanalytical services, we are committed to supporting the growth and innovation of the biotech industry. This premier event offers a unique platform to engage with industry experts, innovators, and decision-makers, all working…